Clinical Trials of Biosimilars

As the demand of Biosimilars is ever increasing in the pharmaceutical market, it is very important to check them properly before releasing it to the mass. That is why there is a stepwise approach towards clinical trials of Biosimilars. It has various levels such as Extensive Molecular characterization Program, Pre-Clinical, Phase 1, Phase 3, Phase 4 and so on.

 

  • Biosimilars Clinical Studies
  • Biosimilars Toxicological studies
  • Targeted cell line development
  • Transgenic animals
  • Case studies and clinical models
  • Risk management and quality affairs
  • Clinical trials on major diseases

Related Conference of Clinical Trials of Biosimilars

Clinical Trials of Biosimilars Conference Speakers